An IND is submitted to the FDA following the successful completion of Phase 3 clinical trials.

Name: An IND is submitted to the FDA following the successful completion of Phase 3 clinical trials.
Brand: Quizplus
Rating: 4.9 (64 reviews)

Question

Quizplus · Accepted Answer

An IND (Investigational New Drug application) is submitted to the FDA before the commencement of clinical trials, not after Phase 3. It is necessary to obtain approval to start human testing, which begins with Phase 1 clinical trials.

An IND Is Submitted to the FDA Following the Successful